Evidence map›Paper›PMID 26843621›Full record

ArticleOncotarget2016

The energy sensor AMPK regulates Hedgehog signaling in human cells through a unique Gli1 metabolic checkpoint.

Laura Di Magno, Alessio Basile, Sonia Coni, Simona Manni, Giulia Sdruscia, Davide D'Amico, Laura Antonucci, Paola Infante, Enrico De Smaele, Danilo Cucchi and 4 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Article
  3. SALL4 is a CRL3Cell death and differentiation · 2024
    Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Cell communication and signaling : CCS · 2019
    Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Laura Di MagnoCenter for Life Nano Science@Sapienza, Istituto Italiano di Tecnologia, 00161 Roma, Italy.
Alessio BasileDepartment of Molecular Medicine, Sapienza University of Rome, 00161 Rome, Italy.
Sonia ConiDepartment of Molecular Medicine, Sapienza University of Rome, 00161 Rome, Italy.
Simona ManniDepartment of Molecular Medicine, Sapienza University of Rome, 00161 Rome, Italy.
Giulia SdrusciaCenter for Life Nano Science@Sapienza, Istituto Italiano di Tecnologia, 00161 Roma, Italy.
Davide D'AmicoDepartment of Molecular Medicine, Sapienza University of Rome, 00161 Rome, Italy.
Laura AntonucciDepartment of Molecular Medicine, Sapienza University of Rome, 00161 Rome, Italy.
Paola InfanteCenter for Life Nano Science@Sapienza, Istituto Italiano di Tecnologia, 00161 Roma, Italy.
Enrico De SmaeleDepartment of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy.
Danilo CucchiDepartment of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy.
Elisabetta FerrettiDepartment of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy.
Lucia Di MarcotullioDepartment of Molecular Medicine, Sapienza University of Rome, 00161 Rome, Italy.
Isabella ScrepantiDepartment of Molecular Medicine, Sapienza University of Rome, 00161 Rome, Italy.
Gianluca CanettieriDepartment of Molecular Medicine, Sapienza University of Rome, 00161 Rome, Italy.
Sapienza University of Rome · ITItalian Institute of Technology · ITIstituto Pasteur · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hedgehog signaling controls proliferation of cerebellar granule cell precursors (GCPs) and its aberrant activation is a leading cause of Medulloblastoma, the most frequent pediatric brain tumor. We show here that the energy sensor AMPK inhibits Hh signaling by phosphorylating a single residue of human Gli1 that is not conserved in other species. Studies with selective agonists and genetic deletion have revealed that AMPK activation inhibits canonical Hh signaling in human, but not in mouse cells. Indeed we show that AMPK phosphorylates Gli1 at the unique residue Ser408, which is conserved only in primates but not in other species. Once phosphorylated, Gli1 is targeted for proteasomal degradation. Notably, we show that selective AMPK activation inhibits Gli1-driven proliferation and that this effect is linked to Ser408 phosphorylation, which represents a key metabolic checkpoint for Hh signaling. Collectively, this data unveil a novel mechanism of inhibition of Gli1 function, which is exclusive for human cells and may be exploited for the treatment of Medulloblastoma or other Gli1 driven tumors.

Indexed as

3T3 CellsAMP-Activated Protein KinasesAnimalsCell LineCell ProliferationCerebellar NeoplasmsHedgehog ProteinsHEK293 CellsHumansMedulloblastomaMicePhosphorylationRNA InterferenceRNA, Small InterferingSignal TransductionZinc Finger Protein GLI1AMP-Activated Protein KinasesGLI1 protein, humanHedgehog ProteinsPRKAA1 protein, humanPRKAA2 protein, humanRNA, Small InterferingSHH protein, humanZinc Finger Protein GLI1AMPKcancer metabolismGli1Hedgehogphosphorylation

Identifiers

PMID26843621
PMCPMC4891058
OpenAlexW2273708684

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.